论文部分内容阅读
目的:观察并比较荷丹片与非诺贝特治疗2型糖尿病合并高脂血症的疗效。方法:45例2型糖尿病合并高脂血症病人应用荷丹片,2片,po,tid;另45例应用非诺贝特0.2 g,po,qd;观察8周。结果:荷丹片治疗有效率为93.33%,非诺贝特为97.62%,两组治疗前后比较,有统计学差异(P<0.05),两组间比较无统计学差异(P>0.05)。结论:荷丹片降脂作用明显,且副作用小,安全、可靠,适用于2型糖尿病合并高脂血症的治疗。
OBJECTIVE: To observe and compare the therapeutic effect of Hordan tablets and fenofibrate on type 2 diabetes with hyperlipidemia. Methods: Forty-five patients with type 2 diabetes mellitus and hyperlipidemia were treated with holin tablets, 2 tablets, po, tid. The other 45 cases were treated with fenofibrate 0.2 g, po, qd for 8 weeks. Results: The efficacies of Haldane tablets were 93.33% and fenofibrate was 97.62%. There was a significant difference between the two groups before and after treatment (P <0.05). There was no significant difference between the two groups (P> 0.05). Conclusion: Houdan tablet has obvious lipid-lowering effect and little side effect, which is safe and reliable. It is suitable for the treatment of type 2 diabetes with hyperlipidemia.